Equities

Alexium International Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Alexium International Group Ltd

Actions
  • Price (EUR)0.001
  • Today's Change0.001 / 100.00%
  • Shares traded3.00
  • 1 Year change0.00%
  • Beta1.3711
Data delayed at least 15 minutes, as of Mar 03 2026 07:06 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Alexium International Group Limited is a performance chemicals provider for advanced materials applications with a focus on flame retardancy and thermal management. The Company’s principal activities include research and development in consultation with end customers, obtaining patents in relation to new products developed and manufacturing, sales, and distribution of products. Its product solutions include thermal regulation and flame retardant. Its brands include AlexiCool, AlexiFlam, Eclipsys, BioCool and DelCool. AlexiCool represents the Company’s original and adopted microencapsulated phase-change materials (mPCM) cooling technology, designed for textile and foam applications. Eclipsys is its proprietary, IP-protected perpetual cooling technology for textiles and foam-based products. BioCool is a proprietary, biobased mPCM line of products for the bedding industry. Its AlexiShield is a water-resistant flame-retardant solution for providing enhanced flame resistance in mattresses.

  • Revenue in AUD (TTM)5.57m
  • Net income in AUD-5.52m
  • Incorporated1994
  • Employees319.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AJX:ASX since
announced
Transaction
value
Microtek Laboratories Inc-Microencapsulation & PCM BusinessDeal completed15 Dec 202515 Dec 2025Deal completed-20.00%2.17m
Data delayed at least 20 minutes, as of Mar 02 2026 23:11 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.